Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality worldwide, encompassing conditions such as coronary artery disease and stroke. The growing occurrence of ASCVD, fueled by elevated risk factors, cardiovascular disease, and diabetes, is contributing to an expanding market for pharmaceuticals, medical devices, and diagnostic tools, as it impacts a substantial segment of the population.
According to our analysis, the total diagnosed prevalent cases of ASCVD in the 7MM were 55 million cases in 2022 and this number is predicted to climb at a substantial CAGR throughout the research period (2019–2032). DelveInsight’s analyst ha...
